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Recently, the Editor of the Journal telephoned us with a “crazy idea.”He read a few phrases from the “Patients and Methods” section ofour paper “Superficial Adenocarcinoma of the Esophagus” (whichappears in this issue1) and thought most readers would understandthe first phrase, perhaps 50% the second, maybe 10% to 25% thethird, and but a handful the fourth. His idea was to call a time-out
to bring readers up to speed on statistical methodology. He suggested we extract key
phrases from our paper and explain them in the format of a Clinical-Pathologic
Conference (CPC).
His selection of “Superficial Adenocarcinoma of the Esophagus” is interesting,
because the intensity of statistical analysis required to unlock the meaning of the
data is high. Further, the article appears in the General Thoracic Surgery section,
introducing into that arena data analysis concepts and methods more frequently
found in the cardiac surgery sections.
Before proceeding, please read the paper.
Each section of the CPC is introduced by quotations from the paper and followed
by dialogue between Drs Rice (TWR) and Blackstone (EHB). Throughout the dia-
logue, key technical ideas are highlighted for discussion in marginal notes. We rec-
ommend two sources of supplemental information: chapter 71 of Thoracic Surgery2
and chapter 6 of Cardiac Surgery.3
Essence of the Article
Surgery is the treatment of choice for superficial adenocarcinoma of the
esophagus. The ideal patient has high-grade dysplasia found at surveillance,
good pulmonary function, and undergoes a transhiatal esophagectomy.
Discovery of N1 disease or development of postoperative pulmonary compli-
cations necessitating reintubation reduces the benefits of surgery. (Ultramini-
Abstract)
EHB: Dr Rice, for readers unfamiliar with superficial adenocarcinoma of the
esophagus, what instigated this study? 
TWR: Adenocarcinoma arising in Barrett esophagus is occurring with increasing
frequency, resulting in more patients presenting with cancers confined to the mucosa
or submucosa—superficial adenocarcinoma. These patients are likely to be cured by
operation. Thus, my initial motivation was to provide a gold standard to which exper-
imental alternatives to esophagectomy for early-stage disease could be held.
While analyzing the data and writing the manuscript, we realized that death
from cancer was not the primary determinant of outcome. Rather, it was comor-
bidity, surgical factors, and postoperative mortality and morbidity. This
From the Department of Thoracic and
Cardiovascular Surgerya and the Department
of Biostatistics and Epidemiology,b The
Cleveland Clinic Foundation, Cleveland,
Ohio.
Received for publication April 6, 2001; revi-
sions requested May 23, 2001; revisions
received Aug 24, 2001; accepted for publica-
tion Aug 30, 2001.
Address for reprints: Eugene H. Blackstone,
MD, The Cleveland Clinic Foundation, 9500
Euclid Ave, Desk F25, Cleveland, OH 44195
(E-mail: blackse@ccf.org).
J Thorac Cardiovasc Surg 2001;122:1063-76
Copyright © 2001 by The American
Association for Thoracic Surgery
0022-5223/2001 $35.00 + 0 12/1/119858
doi:10.1067/mtc.2001.119858
Clinical-Pathologic Conference: Use and choice
of statistical methods for the clinical study,
“Superficial adenocarcinoma of the esophagus”
Eugene H. Blackstone, MDa,b
Thomas W. Rice, MDa
TX
ET
CP
B
A
H
D
ST
AT
S
G
TS
ED
IT
O
RI
A
L
Statistics
for the
Rest of Us
See related article on page 1077.
Drs Rice and Blackstone
1064 The Journal of Thoracic and Cardiovascular Surgery • December 2001
ED
ITO
RIA
L
STATS
G
TS
A
H
D
ET
CPB
TX
Statistics for the Rest of Us Blackstone and Rice
changed the focus of the paper and enriched its clinical
applicability.
EHB: Good long-term outcome in these patients sug-
gested that the goals of treatment be surgical mortality and
morbidity approaching zero. These are goals more typical of
coronary artery bypass grafting than cancer palliation.
Crafting a Road Map for the Reader
The purposes of this study were to (1) evaluate the
results of surgical management of superficial adeno-
carcinoma of the esophagus and (2) identify predic-
tors of long-term survival for (a) decision-making
(preoperative factors), (b) prognostication (operative
factors), and (c) hospital care (postoperative compli-
cations). (Introduction)
TWR: The statement of purpose grew out of our iterative
work with the data and results. It was not a linear process
from hypothesis to inference. Pursuits of many leads were
abandoned. Insights gained generated new questions, which
in turn dictated new analyses, producing new insights.
These are the dynamics of a serious clinical study. 
EHB: When we finally understood the meaning of the
data from this iterative process, we distilled its essence into
an Ultramini-Abstract.4 From that, we developed a state-
ment of purpose. The “Results” section was organized and
the “Patients and Methods” section structured in exact
alignment with the statement of purpose. The words match
exactly. Thus, the paper has an explicit and consistent road
map to guide the reader as it guided the writers.
Defining the Study Group
From our prospective surgical database of 577 patients
undergoing resection of esophageal carcinoma at The
Cleveland Clinic Foundation beginning January 1983,
122 patients were found to have superficial adenocar-
cinoma of the esophagus. (Patients and Methods)
TWR: It is crucial to define the study group. This may
seem simplistic, but it is not. When I came to The Cleveland
Clinic, I started a registry of esophageal surgery that
evolved into a prospective database. A registry prevents
patients from falling through the cracks and from other
biases of ascertainment.
EHB: Characterization of the study group includes con-
text of care (the specific institution), time frame, and popu-
lation from which the group was drawn. 
Moving Target: Trends Across Time
The number of patients operated on increased across
time. . . . The surgical technique evolved from routine
thoracotomy to transhiatal esophagectomy with
lymph node sampling for those patients with a low
risk of lymph node metastases. . . . These models
include factors whose prevalence changed across
Margin Notes 
Ultramini-Abstract 
The Ultramini-Abstract was introduced to convey the essence
of a study’s findings.4 It is generally two or three sentences
long (50 words maximum for The Journal of Thoracic and
Cardiovascular Surgery). 
The maximum word length of the Ultramini-Abstract
resulted from an experiment by the editorial office. A couple
dozen manuscripts submitted to the Journal were reviewed,
and 25-, 50-, 75-, and 100-word summarizing statements were
generated and evaluated. Twenty-five words (one sentence)
proved too few to capture the essence of most papers. Seventy-
five words read like a condensed abstract. On occasion, the
essence of a study could not be captured in 50 words. Such
manuscripts contained too many ideas (information content
overload); they needed to be split into two or more papers.
Although ostensibly intended for readers, an ultramini-
abstract helps writers focus on the truest statements they can
make from their understanding of a study’s information, data,
and analyses. It is the best preparation for writing a manuscript. 
Prevalence, Incidence, Rate
Prevalence, incidence, and rate are used interchangeably.
Perhaps common usage should prevail, because it rarely leads
to confusion. But it is not accurate. We prefer selecting the spe-
cific word whose technical definition matches the context. 
Prevalence is the frequency of occurrence of some factor,
characteristic, event, or incident in a group. Of the three words
being considered, it is the least commonly used but the most
commonly meant! For example, Table 2 of the paper indicates
that between 1985 and 2000 at The Cleveland Clinic, the
prevalence of high-grade dysplasia among 122 patients under-
going esophagectomy was 38 patients, or 31%.
Incidence is frequency of occurrence per unit of time. It is
expressed on a scale of inverse time (cases per year, deaths per
year), or rate of occurrence. The prevalence of high-grade dys-
plasia in a population is governed by the rate of appearance of
new cases (incidence) and the rate of removal of cases by death. 
Rate as used in scientific contexts is a quantity per unit
time. Speed is a rate: km · h–1; cardiac output is a blood flow
rate: L · min–1. In the context of events, rate is synonymous
with incidence. The hazard function is a rate (deaths · year–1)
and incidence. In the paper, we used hazard functions and so
did not want to confuse incidence and prevalence. 
How, then, can we rephrase such common expressions as
these? 
“Incidence of hospital mortality was. . . .”
“Hospital mortality rate was. . . .”
“Five-year survival rate was. . . .”
We could write, “Prevalence of hospital mortality was. . . .”
However, in most instances, the words prevalence, incidence,
and rate are superfluous. It is better to just write, “Hospital
mortality was. . . .” or “Five-year survival was. . . .”
In other contexts, the word occurrence is a suitable substi-
tute for prevalence. For example, “Pneumothorax occurred
in. . . .” is preferable to “Incidence of pneumothorax was. . . .”
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time. Strategically, we believe that such models are
desirable and more helpful than simply attributing the
improvement in results to a so-called learning curve. . . .
Because the surgical technique and decision-making
changed across time (Appendix I) and simultaneously
early mortality improved (P = .01), we analyzed the
potentially confounding trends across time to identify
if possible those changes that improved results.
(Patients and Methods)
TWR: During the experience, marked changes occurred
in epidemiology, presentation, preoperative evaluation, sur-
gical technique, and postoperative care. Does this evolution
negate analysis of the experience? Can you identify changes
that were for better or for worse?
EHB: This was both an analytic and philosophic chal-
lenge. We faced a moving target. Inferences about the rela-
tion of evolutionary changes to patient outcome were not
protected by a mechanism such as a randomized clinical
trial. If we were “good modelers,” if each change was doc-
umented patient by patient, and if we had sufficient data,
then multivariable analyses could quantify the impact of
changes on outcome.5,6 That is a lot of “ifs!”
Logistic Regression for Time Trends
Management changes were represented by dichotomous
variables (yes or no). A useful method for relating a
dichotomous event, such as a management change, to one or
more explanatory variables is logistic regression. 
Logistic regression uses a mathematical equation known
as the logistic equation.7-9 It is a sigmoid (S-shaped) curve
like the oxygen dissociation curve (Figure 1) and therefore
has intuitive medical relevance when used in risk factor
Figure 1. Relation of an unlimited scale of risk, here expressed in
logit units, to the probability of occurrence of an event. The logis-
tic equation mapping logit units to probability is shown. ln,
Natural logarithm. 
Sufficient Data
A common misconception is that the larger the study group
(called the sample because it is a sample of all such patients,
past, present, and future), the larger the amount of data avail-
able for analysis. However, in studies of outcome events, the
effective sample size for analysis is proportional to the number
of events that has occurred, not the size of the study group.
Thus, a study of 200 patients experiencing 10 events has an
effective sample size of 10, not 200. 
Ability to detect differences in outcome is coupled with
effective sample size. A statistical quantification of the ability
to detect a difference is the power of a study. This is a complex
subject, so only those few aspects of power that affect multi-
variable analyses of events will be mentioned. 
The rule of thumb in multivariable analysis is that the ratio
of events to risk factors identified should be about 10 to 1.5,6
However, the guideline is not specific enough. Many variables
represent subgroups of patients, some of them few in number
(such as 6 patients with T1b N1 disease). If a single patient in
a small subgroup dies, multivariable analysis may identify that
subgroup as one at high risk when, in fact, the variable repre-
sents only this specific patient, not a common denominator of
risk. The purpose of a multivariable analysis is to identify gen-
eral risk factors, not individual patients experiencing events!
Thus, more than 1 event needs to be associated with every
variable considered in the analysis. For our group, sufficient
data means at least 5 events associated with every variable.
However, because variables may be correlated and subgroups
overlap (T1b N1 patients are in the larger subgroup of N1
patients as well as the T1b group), in the course of analysis, the
number of unexplained events in a subgroup may fall below 5,
which is insufficient data.
This strategy could result in identifying up to 1 factor per 5
events. We get nervous at this extreme, but in small studies we
are sometimes close to that ratio. 
Thus, there is both an upper limit of risk factors that can be
identified by multivariable analysis and a lower limit of events
to allow a variable to be considered in the analysis. Sufficient
data, then, implies having enough events available to test for all
relevant risk factors.
Dichotomous Variables
Dichotomous variables are the simplest subset of categorical
variables. They can take on only two different classes or values,
such as yes or no, positive or negative, 0 or 1. A dichotomous
outcome may be called binary data (eg, hospital death). 
Outcomes and Events
Results of therapy are outcomes. A subset of outcomes is
events. Events are expressed in analyses as dichotomous vari-
ables (see above). Outcomes may be related to explanatory
variables (see below), such as death, recurrence of cancer,
functional status after surgery, or postoperative FEV1.
An outcome in one setting can be an explanatory variable in
another. In the paper, management changes were an event in
the context of examining therapy. They were explanatory vari-
ables in the context of an analysis of mortality. 
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analysis. If a risk factor imparts 2 units of risk, a robust
patient, far to the left on the graph in Figure 1, would have
only a small probability of experiencing an event. In con-
trast, a fragile patient, near 0 on the graph, would have a
large probability of experiencing the same event.10,11 In one
form or another, all types of event analyses are based on a
similar S-shaped relation.
Generally, many variables are examined in logistic
regression,12,13 but for time trends, our attention was con-
fined to the date of operation.
Events Occurring After Time Zero
Postoperative complications were recorded and
assessed. (Patients and Methods)
TWR: Outcome of cancer surgery usually is dominated
by cancer mortality. Because so few cancer deaths occurred
in this study, other factors that could influence outcome
were recorded and evaluated, including events occurring
during postoperative care.
EHB: Events occurring after time zero (time of
esophagectomy in this study) generally are not analyzed as
potential risk factors. They are called time-varying covari-
ables and are avoided for compelling reasons. First, because
these events take place after time zero, some patients die
before they occur; this affects the denominator for the analy-
sis. Second, they themselves are outcomes, with their own
risk factors that should be identified. Mortality and other
complications following an occurrence should be studied.
Third, the closer they occur to death, the more apt they are
to be a surrogate for death (confounding). 
We justified examining the influence of events occurring
shortly after time zero as a way to gain insight into issues of
postoperative management. Sequential analysis (discussed
below) prevented our being fooled by confounding.
Formal, Systematic Follow-up
Patients were followed up by periodic clinic visits;
however, cross-sectional systematic follow-up was
made in January 2000. (Patients and Methods) 
TWR: You insisted we attempt to contact all patients we
believed were still alive. Why couldn’t we depend on clinic
notes, simply recording the date patients were last seen?
EHB: Complete, “active,” systematic follow-up of
patients is a necessity. “Passive” follow-up through clinic
visits or inquiries of patients’ physicians is inadequate.
The following hypothetical explanation may help: 100
patients underwent operation on the same day. The goal was
to determine their fate 2 years later. Data were assembled
from clinic visits. Some patients were last seen 6 months
after surgery, others at 10 months, a few at 15 months, and
2 at 2 years. One patient died 30 months after surgery.
Imagine the impossibility of obtaining a meaningful answer
to the status of these 100 patients at 2 years when the status
Statistics for the Rest of Us Blackstone and Rice
Explanatory Variables
The set of variables examined in relation to an outcome is
called explanatory variables, independent variables, corre-
lates, risk factors, incremental risk factors, covariables, or pre-
dictors. These alternative names distinguish this set of
variables from outcomes. No statistical properties are implied.
The least understood name is independent variable (or inde-
pendent risk factor). Some mistakenly believe it means the
variable is uncorrelated with any other risk factor. All it actu-
ally describes is a variable that by some criterion has been
found (1) to be associated with outcome and (2) to contribute
information about outcome in addition to that provided by
other variables considered simultaneously.
Logistic Equation
The logistic equation is P = 1/[1 + e–z], where P is probability,
e is approximately 2.7183 and is known as the base for the nat-
ural system of logarithms (see below), and z is the logarithmic
parameter, specifically, the power to which e is raised. 
The logistic equation was devised to characterize population
growth.7 Berkson and Hollander8 noted that it characterized
a number of biologic phenomena, including the proportion of
erythrocytes lysed as their suspension medium became increas-
ingly hypotonic. Berkson9 made it the basis for bioassay. 
We can rearrange the logistic equation as follows:
P + Pe–z = 1
ez = P/(1 – P)
z = ln(P/[1 – P])
Thus, the logistic equation relates the absolute probability, P, of
an event to an approximation of relative risk known as the odds
ratio. The odds ratio is the proportion of patients experiencing
an event divided by the proportion of patients not experiencing
it (1 – P, the so-called complement of P): P/(1 – P). To convert
the odds ratio to a limitless scale (going from minus infinity to
plus infinity), its logarithm is used, z. Dr Berkson called the
units of this scale “logit units.”10
Logistic Regression
In the 1960s, Jerome Cornfield12,13 suggested the logarithmic
odds ratio (log odds) parameter z of the logistic equation be the
carrier of explanatory variables. The mathematical form of z he
suggested was “logit linear”:
z = β∅1 + β1x1 + β2x2 + ··· + βkxk
where the β’s are regression coefficients and the x’s are risk
factors, such as age or FEV1. The β’s translate the measure-
ment scale of the risk factors (x’s) onto the scale of risk (logit). 
An increasing number of risk factors and a larger magnitude
of the relation between a unit change in the value of a risk fac-
tor and risk “move a patient to the right” on the logit scale. This
increments risk commensurate with where the patient started in
the logit curve. 
Since its introduction, logistic regression has become the
most common form of multivariable analysis for non–time-
related events such as hospital mortality, occurrence of postop-
erative events, or use of particular management techniques.
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of only 3 people was known at that time! This is called
numerators in search of denominators.14
In reality, patients undergo operations over a span of
time. One good follow-up strategy is to determine the status
of each patient at a fixed interval after surgery (as in the
example). This is the anniversary method of follow-up.15
Another good method is to ascertain the status of all
patients at a given point in time (called cross-sectional fol-
low-up). This is the common closing date method, which we
employed.16 Anything short of formal, systematic, complete
follow-up by one of these two methods leads to uninter-
pretable survival estimates. 
Descriptive Statistics
Descriptive statistics are summarized as the mean and
standard deviation for continuous variables and as
frequencies and percentages for categorical vari-
ables. (Patients and Methods)
TWR: Surprisingly, as a surgeon trained in technical
details, I may miss the essence of the techniques of analysis
that are introduced with this sentence. Do not be intimidated
by statistics! You need to understand the methods without
performing the statistics!
EHB: Nearly every phrase in this sentence has a techni-
cal meaning. Each also implies assumptions about the data
that the reader is asked to take on faith!
Descriptive statistics means information that characterizes
the study group. It allows readers to appreciate the composition
of this specific group. There are often important geographic
and institution referral differences in clinical studies. To avoid
jumping to the conclusion, “That’s not my experience!,” read-
ers should study the descriptive statistics carefully.
Ideally, patients’ data (stripped of informative identifiers)
would be made available case by case. This is impractical.
Instead, the study group is characterized by summarizing
information. Summarizing information is different for dif-
ferent types of variables. 
Continuous Variables
Some variables, like age, can take on a different value for
every patient. This characterizes a continuous variable. One
way to describe a continuous variable is to list each value.
Cumulative distribution plots do just that. A description of
how a cumulative distributed curve is constructed for age is
given in the legend for Figure 2. The legend explains the
median value (50% older and 50% younger), percentiles,
and quartiles. 
A more abstract way to summarize age is to imagine that
the values fall into a pattern that can be represented by a
bell-shaped mathematical model. Figure 3 is a histogram
showing patient age grouped into 5-year intervals. It looks
somewhat bell-shaped, like the smooth bell-shaped curve
superimposed on it. The bell-shaped curve was constructed
Time Zero
In time-to-event (survival) analysis, time zero is the time at
which every patient in the study becomes at risk of experienc-
ing the event being examined. In this study, time zero was
esophagectomy. 
Fortunately, surgery is an unmistakable event that makes
errors of defining time zero uncommon (although they occur in
particular settings). In medical studies, time zero is often elu-
sive. For example, we do not know time of onset of adenocar-
cinoma of the esophagus. 
Time-varying Covariables
Time-varying covariables are factors, events, or measurements
whose values change after time zero. Typical examples are res-
piratory failure occurring after operation, cancer recurrence,
adjuvant therapy, development of a new medical condition, and
change in blood pressure. Their proper analysis requires spe-
cial mathematics. Their relation to other events, such as death,
must be interpreted with care.
Confounding
A confounder is a variable related both to outcome and to
groups being compared. This presents a challenge, because it is
analogous to the researcher being required to answer the ques-
tion, “Which came first, the chicken or the egg?”
Variable or Parameter?
A variable is an item that can take on different values for dif-
ferent patients. A parameter is a constant. The two terms are
antonyms, yet they are commonly used as synonyms! We rec-
ommend their proper technical usage. Thus, age is a variable,
but mean age is a parameter. 
Mathematical Model
A mathematical model is an equation (or set of equations) rep-
resenting real data. Equations contain symbols representing
parameters whose values are estimated from the data (see
“Parameter Estimates,” page 1069). Mathematical models may
arise from a theory of nature or from empiric observation that
they represent data reasonably. They are “compact” because an
entire set of data is summarized by values of a small number of
parameters in the mathematical model. 
Histograms and Cumulative Distributions
A histogram is a type of bar graph that summarizes the distri-
bution of values of a continuous variable. Categories of the
variable are selected of equal width (eg, 5-year age groups),
and the number of patients in each category is displayed on the
vertical axis. 
In contrast, cumulative distribution curves utilize every
value, not categories of values, and increment monotonically
upward (see Figure 2). The shape of the histogram is roughly
the slope of the cumulative distribution function. 
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from a mathematical equation called the Gaussian (normal)
distribution. The Gaussian distribution equation contains
two constants that characterize its shape. These constants
are parameters. The parameter representing the location
along the horizontal axis of the peak of the curve is called
the mean. The estimate of the mean is average age. 
The other parameter identifies the point of inflection of
the curve on each side of the mean. This is the point of tran-
sition from a steep ascent or descent to the shallower flange
of the bell. The location of the inflection point is a parame-
ter called the standard deviation. The closer patient ages are
grouped together, the closer the standard deviation will be to
the mean. Ages between 1 standard deviation below the
mean and 1 standard deviation above it encompass 68% of
the patients, as can be appreciated in Figure 2. 
The mean and standard deviation are easily computed.
But the computations are misleading if the distribution of
values is asymmetric (skewed). This situation may be
addressed by transformations, such as logarithms, or by
nonparametric statistics, such as percentiles. 
Categorical Variables
In contrast to continuous variables, variables such as sex,
depth of tumor invasion (T), and regional lymph node status
(N) have values representing one of two or one of a small
Statistics for the Rest of Us Blackstone and Rice
Gaussian (Normal) Distribution
The equation of the bell-shaped Gaussian (normal) distribution
curve is 
y = 1 e
(x – µ)2
σ2π
2σ2
where:
π is a constant, approximately 3.1415927 . . ., pi
e is a constant, approximately 2.7183 . . ., the base of the 
natural logarithms
σ is a parameter that represents the standard duration of the 
variable
µ is a parameter that represents the mean of the variable
x represents a value of the variable X, generally graphed on 
the horizontal axis
y represents the probability of occurrence of a particular 
value of x.
Because in medicine normal has several unrelated mean-
ings, we have used the more technical term Gaussian. 
Standard Deviation Versus Standard Error
Standard deviation is the Gaussian distribution parameter rep-
resenting the scatter or deviation of individual values from the
mean. It is a descriptive statistic.
Standard error is the standard deviation of the mean, an
estimate of the precision of the mean (precision is related to
scatter; accuracy is related to lack of bias—systematic devia-
tion from the true value). Unlike the standard deviation, which
is similar in value for large and small samples of data, the stan-
dard error decreases as n increases.
Because the Gaussian curve is symmetric around the mean,
the two parameters of the Gaussian distribution are expressed by
the shorthand mean ± SD, where SD is 1 standard deviation. This
means 68% of patient ages fall between (mean – SD) and (mean
+ SD). This is one instance, not terribly common in statistics, in
which the shorthand ± is used instead of confidence limits.
Misleading Means
Data may not be distributed symmetrically on both sides of the
mean. Often, they are skewed to the right (see below). The typ-
ical postoperative stay may be 6 days, but a few patients stay
30, 200, or more days. The presence of a few long stay values
inflates the estimate of the mean. This typically results in a
standard deviation larger in magnitude than the mean, such as
10 ± 14 days. These parameter estimates imply that 68% of the
stays will range from –4 days to +24 days! Yet, length of stay
can take on only positive values, so –4 days alerts you to sum-
marizing statistics that make no sense. 
Mean and standard deviation are parameters of a specific
model of data distribution. If the Gaussian model does not rep-
resent the data well, it is a bad model, and something else must
be done.
One thing that can be done is to transform the data onto a
scale that is less susceptible to skewness. For example, the data
values might be transformed to logarithmic scale. Logarithms
of positive numbers spread small values and bunch large ones.
The mean value of logarithms may be more normally distrib-
uted and have a sensible standard deviation. The mean, mean –
Figure 2. Cumulative distribution of age at operation for superfi-
cial adenocarcinoma of the esophagus. Each patient’s age is rep-
resented on the curve from youngest to oldest. Each unique age
value increments to the curve by 1/n, where n is the total number
of patients. Notice that 50% of the patients were younger than 64.5
years and 50% were older. This is the median age, expressed by
horizontal and vertical solid straight lines. The coarse dashed
lines enclose the 25th and 75th percentiles (or quartiles), meaning
that 25% of patients were younger than the 25th percentile and
75% were younger than the 75th percentile. For consistency with
the standard deviation, which encloses about 70% of the ages, the
15th and 85th percentiles (15% of ages above and 15% below) are
shown by fine dashed lines. 
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number of categories—hence the name categorical variable.
The number of patients in each category is the frequency.
Because this number varies widely from study to study, it is
customary to express frequencies on a uniform scale,
namely, the number per 100 patients (percent).
Distribution of Times to an Event (Survival Analysis)
Nonparametric estimates of survival were obtained by
the method of Kaplan and Meier. The parametric
method was used to resolve the number of phases of
instantaneous risk of death (hazard function) and to
estimate their shaping parameters (Patients and
Methods). . . . The instantaneous risk of death was
high immediately after the operation, then fell to a
constant level of 4.2% per year. (Results)
EHB: Nonparametric and parametric are key technical
terms. Cumulative distribution curves and histograms of
age (Figures 2 and 3) require no mathematical models con-
taining parameters. They are called nonparametric statis-
tics. In contrast, the bell-shaped curve superimposed on the
histogram of age (Figure 3) is an equation with parameters.
The Kaplan–Meier method produces nonparametric esti-
mates of the distribution of times until death.17 It is analo-
gous to the construction of Figure 2, except that, by
convention, the cumulative distribution of times until death
is turned upside down.
Figure 3. Histogram of age and superimposed Gaussian distribu-
tion curve. Ages of patients have been categorized and counted in
5-year intervals. The smooth curve is a parametric summary of the
distribution of age, expressed as the mean (the vertical line at the
peak of the curve) and standard deviation (enclosed by the finely
dashed vertical lines). It is questionable whether the mean and
standard deviation represent the distribution of these ages well;
yet the Gaussian distribution is often used in this setting because
of tradition or ease of calculation. On the other hand, notice that
the mean on this figure and median on Figure 2 are similar; the
ages enclosed within ±1 standard deviation of this figure are sim-
ilar to those within the 15th and 85th percentiles of Figure 2.
SD, and mean + SD of logarithms are then raised to the power
of the base (called taking the antilogarithm), producing what is
called the geometric mean and its asymmetric confidence lim-
its. Another transformation is the inverse of each value, that is,
its value divided into 1. If the inverse values are normally dis-
tributed, their mean and standard deviation can be found. Then,
the mean, mean – SD, and mean + SD are transformed back to
the original measurement scale, producing the harmonic mean
and its asymmetric confidence limits.
An alternative is to forget about modeling the data alto-
gether. Report the value for which half the patients have a
greater number (median), and present various percentiles (eg,
25th and 75th percentiles or 15th and 85th to be consistent with
the width of a standard duration) described in Figure 2.
Skewness
Skewness is a statistical measure of the asymmetry of distribu-
tion of values for a variable. In medical data, asymmetry is
often characterized by a number of atypically large values for
a variable. Because the number line proceeds from small num-
bers on the left to large ones on the right, asymmetry in the data
distribution is called right skewness. (See “Misleading Means,”
above.) 
Logarithm
A logarithm is the exponent or power of a fixed number, called
the base. When the base is raised to that power (the antiloga-
rithm), the untransformed number is regenerated. Typical bases
are 10 and the number e, whose value is 2.7183 (e is called the
base of the natural logarithms). For example, the logarithms of
the numbers 0.001, 0.01, 0.1, 1, 10, 100, and 1000 to the base
10 are –3, –2, –1, 0, 1, 2, and 3. 
Cumulative Distribution Versus Survival Curve
If all patients in a study have died, the distribution of times
until death can be depicted by a cumulative distribution func-
tion, as in Figure 2. We generally are unable to use this simple
cumulative distribution method because at follow-up not every-
body has died. 
For living patients, the time of death is not yet known; nev-
ertheless, we know they have lived a specific length of time
after time zero. Thus, we have incomplete information about
their length of life, not missing information. The Kaplan–Meier
method (one of many such methods) uses both complete data
(dead patients) and incomplete data (living patients) to estimate
at least a portion of the distribution of time until death.
Patients with incomplete data (living) are called censored.
This term comes from the way governments determine popula-
tion survival from census figures, that is, by counting living
people.
Parameter Estimates
Parameters in mathematical models are placeholders for
numeric values. When the parameters take on numeric values,
the model becomes an equation that can be solved, for exam-
ple, for individual patients’ risks. 
1070 The Journal of Thoracic and Cardiovascular Surgery • December 2001
ED
ITO
RIA
L
STATS
G
TS
A
H
D
ET
CPB
TX
A parametric method using a mathematical model can
also characterize the distribution of times until death.18
Because such distributions are rarely bell-shaped, models
more suited to survival data are used. Raw survival data are
used to estimate the parameters (constants) of these mod-
els. The parametric method used in this paper was based on
mathematical models of the birth–life–death process.19
Such models incorporate an expression for the rate of tran-
sition from life to death, called the hazard function.18 They
are identical to biochemical kinetics models, with reaction
rate analogous to hazard function.20
In this study, the instantaneous rate of death was high
immediately after surgery, then fell rapidly to a steady value
after about 6 months. A steady hazard (constant hazard)
results in survival decreasing exponentially. 
Risk factors can modulate the hazard function. In this
study, they raised and lowered the constant hazard rate.
Multivariable Analysis
Value of a Sequential Strategy
The strategy for the multivariable analysis used a
sequential approach to variables that reflects the pur-
poses of the study (Methods and Materials). . . .
Decision Model. . . . Prognostic Model. . . . Hospital
Care Model (Results).
TWR: I needed to know what elements of the data were
important during successive phases of patient care. What
information is important for decision-making before a
planned operation? How is prognosis refined after esophagec-
tomy by pathologic stage? What is the survival impact of
unforeseen events occurring early postoperatively?
EHB: Providing information helpful in each phase of
clinical care required a sequential approach to multivariable
analysis. Initially, only preoperative variables and their rela-
tion to outcome were examined. Then, pathologic variables
were added and superceded information removed (eg,
pathologic stage for clinical stage). Finally, postoperative
events were added to the analysis. 
TWR: This is a “medical” approach to multivariable
data analysis. It is an advantage to have a colleague who
knows the statistical methodology and has participated in
patient care.
Concepts
EHB: For many, multivariable analysis is a mystery. We
know intuitively that a patient’s outcome is related to many
variables. We measure or observe and record variables,
some of which may be associated with outcome, even if
they are not directly causal. One goal of multivariable
analysis is to identify, from among the many recorded vari-
ables, those most related to outcome (risk factors). 
Risk factor identification is challenging in medicine,
because many variables are correlated with one another. For
Statistics for the Rest of Us Blackstone and Rice
Numeric values are called parameter estimates. They are esti-
mates because they are based on a finite sample of data. Just as a
mean value (a parameter estimate) is associated with uncertainty
proportional to both the standard duration and effective sample
size, so any parameter estimate is associated with uncertainty.
Parameter values are estimated by means of statistical the-
ory and procedures. The estimation process may be complex or
as simple as counting and dividing (to estimate a probability). 
Hazard Function
The hazard function is the instantaneous risk of death or other
time-related event. 
If the hazard function is steady across time, it is called a
constant hazard or linearized rate. It is easily estimated by
dividing the number of events by the total of follow-up time for
that event. A constant hazard results in survival decreasing
exponentially. This is analogous to exponential radioactive
decay driven at a constant rate, called the half-life. 
In most medical settings, the hazard function is not con-
stant. The human population hazard function is high at birth,
diminishes rapidly, is relatively flat for a few decades, and then
rises with advanced age (sometimes called a bathtub-shaped
hazard function).
The units of hazard are inverse time. Because it is instanta-
neous, the magnitude of the hazard function can be huge for a
short while, such as immediately after surgery. If the duration
of high hazard is brief, few deaths will ensue, however. 
Multivariable Versus Multivariate
Multivariable analysis is an analysis of a set of explanatory vari-
ables with respect to a single outcome variable. Multivariate
analysis is an analysis of several outcome variables simultane-
ously with respect to explanatory variables. 
Before modern multivariate analysis was possible, the terms
most used for a multivariable analysis were “multiple” or “mul-
tivariate.” Since the advent of methods to analyze multiple out-
comes simultaneously, multivariable has come to be associated
with simple outcomes analysis in the American literature.
European literature groups these together as multivariate, per-
haps because multivariable analysis is the degenerate form of
multivariable analysis when number of outcomes is 1. 
Strength of Association
The strength of association of a risk factor with outcome is
expressed by a type of parameter called a coefficient. A coeffi-
cient is a multiplier in an algebraic expression. For example, in
the expression 0.026 × age, 0.026 is the coefficient and multi-
plier of age. The coefficient translates units of age into units of
age-associated risk. 
Most multivariable models consist of an additive relation
among risk factors, as shown for logistic regression. That is,
each variable in the analysis, such as age, FEV1, or type of can-
cer, is weighted by its coefficient (generally, the larger the
weight, the stronger the association with outcome). Then, the
product pairs of the coefficient and variable are added together
with all other pairs to form a risk score. 
can lead to restrictive prespecifying of variables to be exam-
ined, which may preclude generation of new knowledge.
Organizing Variables
The potential risk factors (variables) were organized
for analysis. . . . (Patients and Methods)
TWR: The key to your analyses is grouping similar risk
factors. Is this a more powerful strategy than considering
each factor as it appears in an unordered list?
EHB: Organization of well-understood, high-quality
variables is key to successful, medically informed model-
ing of outcomes. To the casual statistical consultant, all
variables are equal. Under such circumstances, chances are
reduced that the analyses will “turn out right.” In a collab-
orative effort, those analyzing the data become familiar
with each variable, what it means, how its values were
gathered, its quality in terms of accuracy and precision,
and other knowledge and understanding of the variables,
patients, and goals of the study. From this intimate knowl-
edge of the variables, we group them into medically mean-
ingful classes.
We consider the class of variables as “the” variable and
the individual variables within the class as minor differences
in specification. To illustrate, we consider “patient size” as
the variable, but it may be represented by height, weight,
body surface area, or body mass index.
Blackstone and Rice Statistics for the Rest of Us
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example, women on average are shorter and have a smaller
body surface area than men; sex, height, and body surface
are correlated. Risk factors are identified in a context that
accounts for correlated information by evaluating all vari-
ables simultaneously. The strength of association with out-
come of each variable is adjusted for all other variables in
the analysis. Thus, it is correct to think of this strength as the
incremental risk the variable adds beyond that contributed
by all other simultaneously considered variables.
The number of variables that can be in a model simulta-
neously is limited by the number of events, not total n. (See
“Sufficient Data.”) Thus, although we might like to consider
all variables at once and then trim down the list (called a
backward variable selection strategy), in this study, with a
limited number of events, we built the model gradually from
simple (few variables) to more complex (greater number of
variables) using a forward variable selection strategy. 
When the number of events is small, we recommend
developing a parsimonious multivariable model (the sim-
plest model that adequately explains the data).19 Thus, the
analysis is directed toward finding the common denomina-
tors of the event.3
Understanding the Variables
Initial screening of variables possibly related to sur-
vival used the log-rank test and the Cox proportional
hazards model. (Patients and Methods)
TWR: Because many factors influence patient survival,
it is necessary to use multivariable analysis. So what good is
screening variables one at a time and presenting univariable
results?
EHB: We screen individual variables to answer a couple
of questions. First, are there sufficient data for analysis? As
noted earlier, if there are fewer than about 5 events associ-
ated with a subgroup of patients, we cannot use this sub-
group for multivariable analysis. Second, is there a
proportional hazards relationship between a variable and
outcome? By proportional hazards, we mean the ratio of
hazard when a risk factor is present to that when it is absent
is constant across time. This assumption of Cox propor-
tional hazards modeling must be verified if that method of
risk factor analysis will be used.21
Truthfully, other than “weeding out” variables and test-
ing assumptions, I pay little attention to univariable survival
tests. What is important is the multivariable relations. Thus,
I do not prescreen to get rid of otherwise perfectly good but
not univariably statistically significant variables. There are
instances in which the relation of a variable to outcome is
hidden in univariable analyses, and not until other factors
have been accounted for is it revealed. These are called lurk-
ing variables.22
A controversial use of screening is to restrict the number
of variables examined in the multivariable analysis.23 This
Checking the Proportional Hazards Assumption
Whenever Cox proportional hazards analysis is performed, the
assumption of proportional hazards must be verified. The Cox
model is formulated for a single dichotomous variable as follows:
Λ(t) = Λ0(t)eβ1x1
where Λ(t) is the cumulative hazard function, Λ0(t) is the
underlying cumulative hazard (not specified explicitly), e is
2.7183. . ., the base of the natural logarithm, β1 is the Cox
regression coefficient, and x1 is the dichotomous variable.
The ratio of cumulative hazard with the factor present (x1 =
1) to that with it absent (x1 = 0) is
Λ(t,x1 = 1) 
= eβ1
Λ(t,x1 = 0)
Taking logarithms:
β1 = ln[Λ(t,x1 = 1)] – ln[Λ(t,x1 = 0)]
Notice that the logarithm of the two cumulative hazard curves
is separated across all time by β1. If separation is not constant,
the proportional hazards assumption is violated.
Cumulative hazard is estimated from the survival curve S(t)
by taking the logarithm:
Λ(t) = – ln[S(t)]
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Calibration
Continuous and ordinal variables were assessed uni-
variably by decile risk analysis to suggest transfor-
mations of scale to incorporate into the multivariable
analyses to ensure that the relation of these variables
to outcome was well calibrated with respect to model
assumptions. (Patients and Methods)
TWR: Many investigators stratify continuous variables
into two (or a few) groups and analyze the resulting cate-
gories. I notice that you always analyze continuous vari-
ables as such. Is this just a difference in style?
EHB: Continuous variables contain information unique to
each patient. Creating categorical variables from continuous
variables wastes precious information. Generally, the cut points
(points of categorization, such as age > 70 years) are arbitrary.
This practice flies in the teeth of a philosophical idea: continu-
ity in nature.19 A 69.9-year-old is more like a 70.1-year-old than
a 59-year-old or an 85-year-old. We nearly always find that con-
tinuously valued risk factors follow a smooth gradient of risk
that supports the idea of continuity in nature.
There is a scientific argument as well. We are interested
in knowing the shape of the relationship of the variable to
outcome. You cannot characterize the shape if you begin by
categorizing continuous variables.
TWR: I remember your asking me, “At what value is
FEV1 [1-second forced expiratory volume] associated with
reduced survival?” I said, “About 2 L.” As plotted in the
paper’s Figure 5, this is indeed the case. However, this rela-
tionship is not continuous. It is flat to about 2.2 L; then it is
associated with decreasing survival.
EHB: This particular shape was suggested by a calibra-
tion process that took the form of linearizing transforma-
tions. Figure 4, A, shows a scale of risk along the vertical axis
and FEV1 on the horizontal axis. The relation of FEV1 to the
scale of risk is not perfectly linear. Figure 4, B, shows a trans-
formed scale FEV1, and the points now line up straighter.
This is what is meant by a linearizing transformation.
When we “unwound” the transformation for FEV1, it
became evident that above about 2.2 L there was little
increment in risk and below it, a substantial and steep gra-
dient of risk. Thus, we had discovered the shape of the
relationship.
Managing Missing Values for Variables
Informative imputation for missing values of pul-
monary function tests used a multiple regression
model based on available function tests, age, and sex.
(Patients and Methods)
TWR: A number of patients did not have pulmonary
function tested preoperatively. If these patients were dis-
carded, their other data would be wasted.
EHB: Most investigations of missing data have been in
social science, where it makes sense to discard from analy-
sis individuals who fail to return their survey. Less attention
has been given to sporadic missing data, characteristic of
clinical studies. 
For sporadic missing data, we usually impute (substitute)
the mean value of patients with nonmissing data. We verify
the imputed data are noninformative (that is, they do not add
information that biases the results of analysis) by forming
indicator variables. These identify patients in whom values
for a particular variable have been imputed. The indicator
variables are incorporated into analyses to test whether
patients with missing data behave differently with respect to
outcome than patients with available data.
In the case of pulmonary function tests in this study,
more than a small amount of data was missing. Therefore,
knowing that medical data contain correlated variables, we
performed informative imputation. Specifically, we substi-
tuted a value based on other variables correlated with pul-
monary function, rather than the mean for the whole group.
To do this, we performed a multivariable analysis of pul-
monary function tests from patients with nonmissing mea-
surements. This generated an equation to predict pulmonary
function of those patients based on age and sex.23
Identifying the Risk Factors
Multivariable survival analysis was performed for
each hazard phase using a directed technique of entry
of variables into the multivariable models. (Patients
and Methods)
Statistics for the Rest of Us Blackstone and Rice
Accuracy Versus Precision
Accuracy is the absence of systematic error of measurement
(bias) from the “truth.” Precision is the ability to provide the
same answer in repeated measurements. These terms are com-
monly interchanged, but in data analysis they are different.
Scales may be inaccurate because of an offset of weight or
incorrect calibration. However, they may yield repeatable (pre-
cise), inaccurate readings. A measurement may be imprecise
because of inability to obtain consistent results, because the
scale may be too coarse, or because of interobserver error.
Linearizing Transformations
To linearize the relation between the measurement scale of a
continuous or ordinal variable and the scale of risk may require
transformation of the measurement scale. Transformations of
scale might include inverse, logarithm, power, root (such as
square root), and so on. The right transformation produces a
scale linearly related to risk. 
Other techniques can be used to ensure a linear relationship
between risk and measurement scales that, together, we call
calibration. Calibration is extra work! Busy statisticians may
not be given (or take) the time necessary to explore calibration.
It is worth the time!
factors. A P = .1 criterion for retention of variables in
the final models was used. (Patients and Methods)
TWR: I thought statistically significant meant P < .05.
EHB: The requirement of at least 19:1 odds (P < .05) to
reject the idea that the relationship of a variable to outcome
is unlikely to be due to chance is attributed to Sir Ronald
Fisher.25 Actually, he selected this value for a specific agri-
cultural experiment, warning the reader that each new situ-
ation requires establishing appropriate odds to distinguish a
relationship from chance. 
P is highly dependent on effective sample size. If there is
not much data, it is hard to find risk factors based on P! To
avoid overlooking risk factors in small studies, we may
choose P < .1 or P < .2 for inclusion of variables in the mul-
tivariable analysis. This is called avoiding a type II statisti-
cal error. On the other hand, a spurious variable may be
identified as a risk factor by chance. This is a type I statisti-
cal error. So there is danger of both type I and type II errors
that must be balanced. 
Bootstrap Bagging—What It Can and Cannot Do
Because of small study size, bootstrap resampling was
used to validate the models. . . . Thus, the risk factors
were not only identified as statistically significant by
traditional analysis, but also occurred the most fre-
quently in bootstrap analysis. The tables of risk factors
include frequency of occurrence from multivariable
Blackstone and Rice Statistics for the Rest of Us
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TWR: When you use words like “directed variable
selection,” I get nervous. It sounds like multivariable analy-
sis is art, not science.
EHB: My former colleague, Dr David Naftel of the
University of Alabama at Birmingham, enumerated the rea-
sons why different investigators might obtain different mod-
els using the same data set.24 One source of difference is the
approach to model building. 
We do a lot of “hand work,” directed by extensive statis-
tics about variables not yet in the model, but adjusted for
those that are. I pay particular attention to the cluster of vari-
ables in each organized category, entering that variable from
each that seems to best represent the category. There is an
art to this. It is an art that employs knowledge about both the
data and the medical condition.
Part of the hand work is sorting out correlations between
variables and possible compensation of one variable for
another variable that incompletely or inadequately relates to
outcome. For example, if age is inappropriately managed at
its extremes, a variable associated with the elderly or the
young may be identified as a risk factor; however, this fac-
tor is merely an adjustment for inadequately calibrating age. 
What Is Magic About P < .05?
However, the early hazard phase, determined from the
data, was calculated to contain only 5 events; thus,
there was limited ability to identify early-phase risk
Figure 4. Calibration of 1-second forced expiratory volume (FEV1) to risk. A scale of risk is given on the vertical
axis (akin to the logit units of Figure 1), and 8 groups of equal numbers of patients according to the value for FEV1
along the horizontal axis. Their mortality, converted to the risk scale, is shown at each closed circle. (The 8th
closed circle cannot be shown because there were no deaths in the 8th group with the highest FEV1s.) A, Linear
scale of FEV1. Clearly, there is a decreasing (more negative) value of risk at higher FEV1 (simple regression line
shown, with explained scatter for these points of 80%). B, Inverse scale of FEV1. Because of the inverse trans-
formation, the lower FEV1s are to the right of the scale and the higher FEV1s to the left. Risk falls from left to
right, unlike in Figure 4, A. There is now tighter correspondence of risk to this rescaling of FEV1 (85% of scatter
explained) than the conventional scale of Figure 4, A.
A B
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bootstrap modeling, as well as conventional magni-
tude and certainty of the association. (Patients and
Methods)
TWR: When you introduced me to bootstrapping, my
hope was that it would multiply the data, eliminating the
limitation of n. That is not how it works, and its role is dif-
ferent.
EHB: Actually, it is the proverbial answer to the
maiden’s prayer, but a different prayer than you had hoped
for! Remember the dilemma that using P value criteria
exposes the investigator to the chance of both spurious risk
factor detection and failure to detect? Remember your accu-
sation of “art, not science” in variable selection?
Recently, a technique has been introduced that is similar
in concept to visual evoked potentials or signal-averaged
electrocardiograms.26 The entire analytic process of variable
selection is subjected to repeated resampling and reanalysis. 
In practice, a patient is drawn at random (using a random
number generator) from the original data set. This begins
the formation of a new data set. Another patient is drawn at
random; it might be the same patient or a different one. This
goes on until a new data set is built with either the same
number of observations as the original or somewhat fewer.
An automated process is then used to select variables. Once
a model is obtained, it is stored in the computer. This entire
process of selecting patients and performing an analysis is
repeated 100 to 1000 times. As the results are averaged, a
“signal” gradually emerges.27 Some variables are repeatedly
found to be risk factors, others only occasionally. The few
that stand out as consistent are reliable risk factors.28
Let me try to put this process into your domain. Imagine a
space alien trying to figure out what a thoracic surgeon is. If
the alien watches randomly throughout the day, it may find the
surgeon asleep, eating, playing baseball with children, exam-
ining a patient, or performing an operation in the thorax. After
repeated examinations of a randomly selected group of tho-
racic surgeons, the picture gradually emerges that this is a per-
son who performs operations for diseases of the lungs,
esophagus, and chest wall. If the alien is observing differences
between thoracic surgeons and people at random, factors like
sleeping and eating and playing with children disappear into
the background and the professional profile emerges.
Presenting Results
Confidence Limits: Expressing Uncertainty of
Inferences
Confidence limits (CL) of proportions are also equiv-
alent to 1 standard error (68% CL) (Patients and
Methods). . . . Two patients died in the hospital after
the operation and 1 within 30 days, for an operative
mortality of 2.5% (CL 1.1%-4.9%). (Results)
TWR: You and Dr John Kirklin introduced confidence
limits into our literature in the late 1960s. I have not seen
many papers recently that utilize them as extensively as you
suggested.
EHB: Their need and utility are as compelling today as
30 years ago. There were 2 deaths in the hospital and 1 out
of the hospital within 30 days in your study. The fact is that
mortality was 2.5%. There is nothing uncertain about this.
However, confidence limits translate an experience of the
past into an estimate of results in future patients. Intuitively,
the smaller the experience, the less certainty that results will
be similar in the future. In this experience, 2.5% mortality
(called the point estimate) is consistent with mortality rang-
ing from about 1% to 5%.
I do not know why surgeons have not found this infor-
mation useful. Even the general public expects pollsters to
give them a “margin of error.”
Multivariable Results
Tables of risk factors identified in the hazard domain
are presented with their regression coefficients rather
than hazard ratio, because the model is not one of
proportional hazards. (Patients and Methods)
TWR: Some years ago you used bullets to indicate risk
factors and possibly a P. Now you use complex tables with
multiple footnotes. In addition, I am accustomed to obtain-
ing hazard ratios from our statistician, but you give me
regression coefficients. Why?
EHB: A multivariable analysis generates an enormous
amount of information about (1) the model’s structure and
estimates of model structural parameters (if one is using
parametric modeling); (2) risk factors identified; (3) magni-
tude of the association of risk factors with outcome
(expressed as coefficients, odds ratios, or hazard ratios); (4)
direction of relation (positive, negative); (5) uncertainty of
association (standard deviation); (6) score on which P is
based; (7) P; (8) covariance structure (documenting interre-
lations among variables); and recently, (9) bootstrap relia-
bility. There is no room to print all of this information!
Therefore, some triage is nearly always necessary (a com-
plete transcription of a multivariable model is also some-
times needed28); bullet points were one approach to triage.
As to why we do not use hazard ratios, the answer is
simpler. Hazard ratios are meaningful under assumptions of
proportional hazards. When we use transformations of scale
and nonproportional hazards modeling, hazard ratios are not
readily interpretable. 
A Picture Is Worth 1000 Words
. . . because the hazard function multivariable analy-
ses are completely parametric (generate an equation),
“nomograms” from the analyses are presented in
which specific values are entered into the equations,
the equations solved, and the results presented graph-
ically with confidence limits. (Patients and Methods)
Statistics for the Rest of Us Blackstone and Rice
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TWR: The value of a parametric analysis is that it pro-
duces an equation that can be solved for any patient with
any risk factor. It is about more than just identifying risk
factors. 
EHB: The solution, moreover, can be presented graph-
ically in what we call nomograms. This was one of the
motivations for our developing a completely parametric
hazard function methodology.18 Thus, I can show you the
relationship of survival and FEV1, or of survival and age,
by solving an equation. I can plot a graph of a patient’s
specific prognosis from the equation.29 This information
is ideal for understanding disease and its treatment, for
making individual patient decisions, and for obtaining
informed consent.
Nomograms require only simple high school level alge-
bra. Values for all variables in the model are multiplied by
their respective coefficients, the products are summed, the
rest of the equation is solved, and a plot is generated.
Internal Verification of Model Adequacy
The accuracy of this model is corroborated by the
comparison to actual deaths (Results). . . . Adequacy
of the prognostic model (Table 5)
TWR: If a person has pN1 disease, prognosis is grim.
Increasing depth of tumor invasion is also related to poorer
survival, by univariable analysis. However, depth of tumor
invasion (T) is related to the probability of having N1 dis-
ease.30 Yet I do not see T in the prognostic model. Why not?
EHB: Patients with greater depth of tumor invasion have
poorer survival that those with more superficial disease.
However, greater tumor invasion is accompanied by other
even more prognostically important factors, such as pN1
disease. After accounting for other factors, depth of tumor
invasion contributed too little additional prognostic infor-
mation to be retained in the multivariable model.
It is possible that small effective sample size precluded
detecting an additional increment of risk related to T or that
the study was too restrictive in the spectrum of T (confined
to superficial carcinomas) to detect a more general trend of
increasing risk with increasing depth of invasion. One of the
beauties of a completely parametric model is that we can
check this out! Using the multivariable model (see “Patient-
specific Prediction”), we calculated expected survival for
each level of tumor invasion.
As Appendix Figure I (paper) shows, there was good cor-
respondence with Kaplan–Meier survival estimates strati-
fied by T. Even though T was not directly represented in the
model, it was adequately accounted for by other variables,
such as pN1.
It would be a mistake to conclude that T is not a risk fac-
tor. Certainly, the greater the depth of tumor invasion, the
worse the survival. However, the poorer prognosis is
accounted for by other factors correlated with T.
Interpreting Results: Importance of an External
Standard
After accounting for pathologic stage, age at opera-
tion became a risk factor. No sharp age cutoff was
identified: the older the patient, the shorter the sur-
vival. However, patients younger than 55 years had
poorer survival than their US population counter-
parts, whereas patients aged 55 to 75 and those more
than 75 years lived about as long as expected.
(Results)
TWR: Before you started the analysis, I believed that we
should not be operating on older patients. You changed my
mind. Certainly, older patients have a more complex hospi-
tal course and poorer survival than younger patients, as you
show in the multivariable model. You have convinced me
that the prognosis of older patients is better and the progno-
sis of younger patients is actually worse. Explain this.
EHB: The problem with age is that it is a risk factor for
mortality for all of us. So I inquired whether the relation
of advanced age to survival was different after surgery
from that expected in the general population. I used gov-
ernment life tables to construct a survival curve for each
patient based on age, sex, and ethnicity. These curves were
then averaged within age groups for convenience of com-
parison.
Although elderly patients had an increased early mortal-
ity, overall they fared about as well as predicted for the gen-
Patient-specific Prediction
Parametric models permit the calculation of patient-specific
survival curves as in Figure 6 (paper).3 These curves can be
generated for alternative treatments and compared with that
actually given.29
Perhaps unappreciated is that a multivariable analysis
reveals differences in survival unsuspected by average survival
expressed by Kaplan–Meier curves. In Figure 6 (paper), the
low-risk and high-risk patient-specific predictions are quite dif-
ferent. Both differ substantially from the average Kaplan–
Meier curve. This is why we should calculate individual sur-
vival probabilities on the basis of information we know. 
Patient-specific predictions also have a role in interval vali-
dation of model accuracy. We use two methods. First, at the
actual time of follow-up or death for each patient, we calculate
predicted survival. Survival is transformed to cumulative haz-
ard. The sum of cumulative hazards across patients will equal
the number of events observed. We then subgroup patients and
verify that the number of predicted deaths is similar to the
number observed in each subgroup.
Another way to verify a model is to generate a patient-specific
survival curve for each patient. The patients are then subgrouped.
We verify that the average of these individual curves corresponds
to actual subgroup Kaplan–Meier survival estimates.
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eral population. Younger patients had a distinctly worse
prognosis than their counterparts in the general population,
even though their survival after surgery was better than for
older patients.
EHB and TWR: Epilogue
This CPC illustrates important facets of clinical investiga-
tion. It shows that collaboration between the clinical inves-
tigator and analyzers of the data is crucial. The knowledge
of these individuals is not mutually exclusive, but shared.
This facilitates a clinically pertinent data analysis and pre-
sentation that has clinical inferences for future patient care.
It also leads to questions for further investigation. Finally, it
maximizes the extraction of useful information from the
data. However, this requires application of ever-changing
technology in data analysis, statistics, and informatics.
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